High incidence of secondary brain tumours after radiotherapy and antimetabolites. (Q48163138)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

High incidence of secondary brain tumours after radiotherapy and antimetabolites (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

adaptive radiation therapy

10 December 2019

main subject

0 references

author

Jeffrey Rubnitz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

M V Relling

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

G K Rivera

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

J M Boyett

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

M L Hancock

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

C A Felix

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

L E Kun

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

A W Walter

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

W E Evans

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

C H Pui

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

English

0 references

publication date

1 July 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

9172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

34-39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

Second malignant tumors after elective end of therapy for a first cancer in childhood: a multicenter study in Italy.

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Second neoplasms after acute lymphoblastic leukemia in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Incidence of second primary tumours among childhood cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Second malignant neoplasms in children: an update from the Late Effects Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Second malignant neoplasms in patients treated for childhood leukemia. A population-based cohort study from the Nordic countries. The Nordic Society of Pediatric Oncology and Hematology (NOPHO).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Family history of cancer and seizures in young children with brain tumors: a report from the Childrens Cancer Group (United States and Canada).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Central nervous system treatment in childhood acute lymphoblastic leukemia. Long-term follow-up of patients diagnosed between 1973 and 1985.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Bioassay program for carcinogenic hazards of cancer chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Association of a purine-analogue-sensitive protein kinase activity with p75 nerve growth factor receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

The Lancet RADIATION-INDUCED HEAD AND NECK TUMOURS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Effect of brain irradiation on blood-CSF barrier permeability of chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Late multifocal gliomas in adolescents previously treated for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Pharmacogenetics of cancer therapy: getting personal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

p53 gene mutations in pediatric brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

Second malignancies in patients treated for childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911079-6

7 January 2021

10.1016/S0140-6736(98)11079-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10406363%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference